Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter and Conference Paper
A Randomised Trial of Two Radiotherapy Schedules in the Adjuvant Treatment of Stage I Seminoma (MRC TE18) — Preliminary Report
Adjuvant post-orchidectomy radiotherapy cures the majority of patients with stage I seminoma, but as approximately 80 per cent would remain relapse-free on surveillance alone, minimising radiotherapy — and hen...